IMII-US T.B7-10 DLD
IMII-US T.B7-10 DLD
ETF · IE00BF2FN646 · A2N7D2 (XDUB)
Overview
No Price
04.11.2025 15:18
Current Prices from IMII-US T.B7-10 DLD
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
TRXG.L
GBX
04.11.2025 15:18
2.782,72 GBX
26,22 GBX
+0,95 %
XETR: XETRA
XETRA
TRDX.DE
EUR
04.11.2025 15:11
31,61 EUR
0,18 EUR
+0,59 %
XLON: London
London
TREX.L
USD
04.11.2025 14:58
36,29 USD
0,05 USD
+0,14 %
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 35,29 M
Company Profile for IMII-US T.B7-10 DLD ETF
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the Bloomberg Barclays US Treasury 7-10 Year Index (the Index).
Get up to date insights from finAgent about IMII-US T.B7-10 DLD

Company Data

Name IMII-US T.B7-10 DLD
Company Invesco US Treasury Bond 7-10 Year UCITS ETF
Primary Exchange XDUB ISE
WKN A2N7D2
ISIN IE00BF2FN646
Asset Class ETF
Sector Financial Services
Industry Asset Management - Bonds
Market Capitalization 97 Mrd.
Country United Kingdom
Currency EUR
Employees -
IPO Date 2019-01-11
Dividends from 'IMII-US T.B7-10 DLD'
Ex-Date Dividend per Share
11.09.2025 0,38 USD
12.06.2025 0,39 USD
13.03.2025 0,39 USD
12.12.2024 0,39 USD
12.09.2024 0,38 USD
13.06.2024 0,38 USD
14.03.2024 0,36 USD
14.12.2023 0,33 USD
14.09.2023 0,32 USD
15.06.2023 0,32 USD

Ticker Symbols

Name Symbol
Frankfurt TRDX.F
London TREX.L
London TRXG.L
XETRA TRDX.DE
More Shares
Investors who hold IMII-US T.B7-10 DLD also have the following shares in their portfolio:
ARCTIC FISH HOLDINGS NK10
ARCTIC FISH HOLDINGS NK10 Share
JCR PHARM.
JCR PHARM. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025